Healthcare -
Biotechnology - NASDAQ - US
$ 0.95
1.6 %
$ 11.4 M
Market Cap
-0.56
P/E
INDP - COST OF REVENUE
Cost of Revenue INDP - Indaptus Therapeutics, Inc.
1.28 K
LAST VALUE
-4.33%
2 YEAR CAGR
-72.78%
5 YEAR CAGR
-45.95%
10 YEAR CAGR